{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:35:00Z","timestamp":1795127700267,"version":"4.10.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.euros.2024.11.008","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T13:50:01Z","timestamp":1733579401000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["High Detection Rates for Prostate-specific Membrane Antigen\u2013avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography\/Computed Tomography"],"prefix":"10.1016","volume":"71","author":[{"given":"Sarah","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ingbritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Dundee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2024.11.008_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2024.11.008_b0010","series-title":"Cancer","author":"Australian Institute of Health and Welfare","year":"2022"},{"key":"10.1016\/j.euros.2024.11.008_b0015","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2024.11.008_b0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.11.008_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/JU.0000000000001375","article-title":"Advanced prostate cancer: AUA\/ASTRO\/SUO guideline part I","volume":"205","author":"Lowrance","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.11.008_b0030","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1016\/S1470-2045(18)30604-1","article-title":"Consensus on molecular imaging and theranostics in prostate cancer","volume":"19","author":"Fanti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2024.11.008_b0035","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3390\/diagnostics12112594","article-title":"PSMA PET-CT in the diagnosis and staging of prostate cancer","volume":"12","author":"Combes","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.euros.2024.11.008_b0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euros.2024.11.008_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2967\/jnumed.117.197160","article-title":"The impact of 68Ga-PSMA PET\/CT on management intent in prostate cancer: results of an Australian prospective multicenter study","volume":"59","author":"Roach","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2024.11.008_b0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/iju.14012","article-title":"How does 68Ga-prostate-specific membrane antigen positron emission tomography\/computed tomography impact the management of patients with prostate cancer recurrence after surgery?","volume":"26","author":"Bianchi","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.euros.2024.11.008_b0055","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy","volume":"34","author":"Tendulkar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2024.11.008_b0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bju.14944","article-title":"Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature","volume":"125","author":"Luiting","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2024.11.008_b0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2967\/jnumed.117.201749","article-title":"68Ga-PSMA-11 PET\/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a psa level of less than 1.0\u00a0ng\/ml: impact on salvage radiotherapy planning","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2024.11.008_b0070","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/ijc.35052","article-title":"Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial","volume":"155","author":"See","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euros.2024.11.008_b0075","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2967\/jnumed.118.220541","article-title":"Detection rate of 18F-choline PET\/CT and 68Ga-PSMA-HBED-CC PET\/CT for prostate cancer lymph node metastases with direct link from PET to histopathology: dependence on the size of tumor deposits in lymph nodes","volume":"60","author":"Jilg","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2024.11.008_b0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13550-023-01059-1","article-title":"Performance and application of the total-body PET\/CT scanner: a literature review","volume":"14","author":"Sun","year":"2024","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euros.2024.11.008_b0085","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00259-021-05282-7","article-title":"Clinical performance of long axial field of view PET\/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET\/CT","volume":"48","author":"Alberts","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2024.11.008_b0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2967\/jnumed.120.250597","article-title":"Performance evaluation of the uEXPLORER total-body PET\/CT scanner based on NEMA NU 2\u20132018 with additional tests to characterize PET scanners with a long axial field of view","volume":"62","author":"Spencer","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2024.11.008_b0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2018.01.006","article-title":"Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen-ligand positron-emission tomography\/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy","volume":"73","author":"Rauscher","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.11.008_b0100","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00259-017-3743-z","article-title":"Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2024.11.008_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.euros.2022.05.011","article-title":"Defining prostatic vascular pedicle recurrence and the anatomy of local recurrence of prostate cancer on prostate-specific membrane antigen positron emission tomography\/computed tomography","volume":"41","author":"Dundee","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2024.11.008_b0110","first-page":"26","article-title":"Salvage radiotherapy after radical prostatectomy: long-term results of urinary incontinence, toxicity and treatment outcomes","volume":"11","author":"van Dessel","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.euros.2024.11.008_b0115","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.3390\/jcm11123311","article-title":"Ga-68-PSMA-11 PET\/CT in patients with biochemical recurrence of prostate cancer after primary treatment with curative intent-impact of delayed imaging","volume":"11","author":"Kunikowska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.euros.2024.11.008_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CCO.0000000000000439","article-title":"Advances in prostate-specific membrane antigen PET of prostate cancer","volume":"30","author":"Bouchelouche","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.euros.2024.11.008_b0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00259-023-06438-3","article-title":"The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy","volume":"51","author":"Adebahr","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2024.11.008_b0130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2024.11.008_b0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/JU.0000000000001698","article-title":"A phase 2\/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET\/CT with 18F-DCFPyL in prostate cancer patients (OSPREY)","volume":"206","author":"Pienta","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.11.008_b0140","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","article-title":"Diagnostic performance of 18F-DCFPyL-PET\/CT in men with biochemically recurrent prostate cancer: results from the CONDOR phase III, multicenter study","volume":"27","author":"Morris","year":"2021","journal-title":"Clin Cancer Res"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168324014307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168324014307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:07:19Z","timestamp":1765336039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168324014307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"alternative-id":["S2666168324014307"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2024.11.008","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Detection Rates for Prostate-specific Membrane Antigen\u2013avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}